589051210	589051210	CD	B-NP	O
|	|	NN	I-NP	O
ICMC	ICMC	NN	I-NP	O
|	|	NN	I-NP	O
19459871	19459871	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
609473	609473	CD	B-NP	O
|	|	CC	I-NP	O
8/29/2001	8/29/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
GERD	GERD	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/9/2001	9/9/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/2/2001	5/2/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LLOPIS	LLOPIS	NNP	B-NP	O
,	,	,	O	O
EVERETTE	EVERETTE	NNP	B-NP	O
270-56-29-3	270-56-29-3	CD	I-NP	O
Tl	Tl	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Leahstock	Leahstock	NNP	B-NP	O
Ra	Ra	NNP	I-NP	O
Fay	Fay	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/3/01	3/3/01	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SOSNOWSKI	SOSNOWSKI	NNP	B-NP	O
,	,	,	O	O
WESLEY	WESLEY	NNP	B-NP	O
NICOLAS	NICOLAS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/23/01	3/23/01	CD	B-NP	O
by	by	IN	B-PP	O
REGALADO	REGALADO	NNP	B-NP	O
,	,	,	O	O
ANDREA	ANDREA	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
70222436	70222436	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-NP	O
req	req	NN	I-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
MAALOX	MAALOX	NN	I-NP	O
PLUS	PLUS	NN	I-NP	O
EXTRA	EXTRA	NN	I-NP	O
STRENGTH	STRENGTH	NN	I-NP	O
15	15	CD	I-NP	O
ML	ML	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Indigestion	Indigestion	NN	I-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/23/01	3/23/01	CD	B-NP	O
by	by	IN	B-PP	O
IBACH	IBACH	NNP	B-NP	O
,	,	,	O	O
RUBEN	RUBEN	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-NP	O
req	req	NN	I-NP	O
AVANDIA	AVANDIA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ROSIGLITAZONE	ROSIGLITAZONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
OCUFLOX	OCUFLOX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
OFLOXACIN	OFLOXACIN	IN	B-PP	O
0.3	0.3	CD	B-NP	O
%	%	NN	I-NP	O
OPH	OPH	NN	I-NP	O
SOLUTION	SOLUTION	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OS	OS	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
50	50	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PRILOSEC	PRILOSEC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLUCOPHAGE	GLUCOPHAGE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
ALTACE	ALTACE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
RAMIPRIL	RAMIPRIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/3/01	3/3/01	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
RAMIPRIL	RAMIPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
ENOXAPARIN	ENOXAPARIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
SC	SC	NN	I-NP	I-protein
Q12H	Q12H	NN	I-NP	I-protein
X	X	SYM	O	I-protein
14	14	CD	B-NP	I-protein
Days	Day	NNPS	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
10/21	10/21	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
LOVENOX	LOVENOX	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
ENOXAPARIN	ENOXAPARIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
SC	SC	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	O	O
90	90	CD	B-NP	O
Days	Day	NNPS	I-NP	O
Starting	Start	VBG	B-VP	O
2	2	CD	B-NP	O
WEEKS	WEEKS	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Immediately	Immediately	RB	B-ADVP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Shad	Shad	NNP	I-NP	O
Palovick	Palovick	NNP	I-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Emmitt	Emmitt	NNP	I-NP	O
Quire	Quire	NNP	I-NP	O
4/26/01	4/26/01	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Procardia	Procardia	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
nifedipine	nifedipine	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
immed	imme	VBD	B-VP	O
.	.	.	O	O

release	release	VB	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Isordil	Isordil	NNP	B-NP	O
,	,	,	O	O
Benadryl	Benadryl	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diphenhydramine	diphenhydramine	NN	I-NP	O
hcl	hcl	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
NIDDM	NIDDM	NNP	B-NP	O
,	,	,	O	O
Hypercholesterolemia	Hypercholesterolemia	NNP	B-NP	O
,	,	,	O	O
h/o	h/o	DT	O	O
DVT/PE	DVT/PE	NNP	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
RLL	RLL	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
cva	cva	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
cerebrovascular	cerebrovascular	JJ	I-NP	I-protein
accident	accident	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
cabg	cabg	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
cardiac	cardiac	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pvd	pvd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63	63	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
MI	MI	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	B-protein
CABGx4	CABGx4	NN	I-NP	I-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	O
PE	PE	NNP	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
CVA	CVA	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
and	and	CC	O	O
h/o	h/o	NN	B-NP	B-protein
recent	recent	JJ	I-NP	I-protein
pneumonia	pneumonia	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
4/25	4/25	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
who	who	WP	B-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
epigastric	epigastric	JJ	I-NP	O
pain	pain	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
x	x	SYM	B-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
notes	note	VBZ	B-VP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
equivalent	equivalent	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
associated	associate	VBN	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
fevers/chills/sweats	fevers/chills/sweat	NNS	B-NP	O
,	,	,	O	O
diarrhea/constipation	diarrhea/constipation	NN	B-NP	O
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
epigastric	epigastric	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
Na	Na	NN	B-NP	B-protein
133	133	CD	I-NP	I-protein
and	and	CC	O	O
Cr	Cr	NN	B-NP	B-protein
1.7	1.7	CD	I-NP	I-protein
,	,	,	O	O
negative	negative	JJ	B-NP	O
tropnin	tropnin	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
0.00	0.00	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
CK	CK	NN	B-NP	B-protein
53	53	CD	I-NP	I-protein
,	,	,	O	O
LFTs	LFT	NNS	B-NP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

RUQ	RUQ	NN	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
gall	gall	NN	I-NP	O
bladder	bladder	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fatty	fatty	JJ	I-NP	O
liver	liver	NN	I-NP	O
and	and	CC	I-NP	O
gallstones	gallstone	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
sonographic	sonographic	JJ	I-NP	O
Murphy	Murphy	NNP	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
showed	show	VBD	B-VP	O
NSR	NSR	NN	B-NP	B-protein
at	at	IN	B-PP	O
80	80	CD	B-NP	O
with	with	IN	B-PP	O
flat	flat	JJ	B-NP	O
T	T	NN	I-NP	O
in	in	IN	B-PP	O
I	I	PRP	B-NP	O
and	and	CC	O	O
flipped	flipped	JJ	B-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
-LRB-	-LRB-	HYPH	O	O
all	all	DT	B-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
V5/V6	V5/V6	NN	I-NP	O
.	.	.	O	O

V/Q	V/Q	NN	B-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
intermediate	intermediate	JJ	B-NP	O
probability	probability	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
pne	pne	NN	I-NP	O
umonia	umonia	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
d-dimer	d-dimer	NN	B-NP	O
800	800	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
+	+	SYM	O	O
LENI	LENI	NNP	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Yuenger	Yuenger	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
reccomended	reccomende	VBN	B-VP	O
starting	start	VBG	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
dose	dose	NN	I-NP	O
lovenox	lovenox	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
50mg	50mg	CD	I-NP	O
sc	sc	NN	I-NP	O
bid	bid	NN	I-NP	O
x	x	SYM	O	O
2	2	CD	B-NP	O
wk	wk	NN	I-NP	O
and	and	CC	I-NP	O
40mg	40mg	NN	I-NP	B-protein
sc	sc	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
mo	mo	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Checked	Check	VBN	B-NP	O
heparin	heparin	NN	I-NP	B-protein
level	level	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
0.9	0.9	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-VP	O
so	so	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
dose	dose	NN	B-NP	O
of	of	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
to	to	TO	B-PP	O
lovenox	lovenox	NN	B-NP	O
40mg	40mg	CD	I-NP	O
sc	sc	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

LENIS	LENIS	NN	B-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
repeated	repeat	VBN	I-VP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
lovenox	lovenox	NN	I-NP	O
.	.	.	O	O

MI	MI	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
adenosine-MIBI	adenosine-MIBI	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
change	change	NN	B-NP	O
vs	vs	IN	B-PP	O
his	his	PRP$	B-NP	O
dobutamine-MIBI	dobutamine-MIBI	NN	I-NP	O
'	'	''	O	O
00	00	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
mild	mild	JJ	B-NP	O
gastritis/GERD	gastritis/GERD	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
medications	medication	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
BID	BID	NNP	I-NP	O
and	and	CC	I-NP	O
Lovenox	Lovenox	NNP	I-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Chadwick	Chadwick	NNP	I-NP	O
Lafone	Lafone	NNP	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
within	within	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
re-assessment	re-assessment	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Frank	Frank	NNP	I-NP	O
Trigleth	Trigleth	NNP	I-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
lovenox	lovenox	NN	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-NP	O
symptoms	symptom	NNS	I-NP	O
or	or	CC	O	O
new	new	JJ	B-NP	O
fevers/chills/sweats	fevers/chills/sweat	NNS	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
for	for	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
teaching/compliance	teaching/compliance	NN	I-NP	O
.	.	.	O	O

Medication	Medication	NN	B-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
serum	serum	NN	B-NP	B-protein
potassium	potassium	NN	I-NP	I-protein
11/3	11/3	CD	I-NP	I-protein
and	and	CC	O	O
send	send	NN	B-NP	O
result	result	VBP	B-VP	O
into	into	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ambrose	Ambrose	NNP	I-NP	O
Rumple	Rumple	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
for	for	IN	B-PP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
and	and	CC	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
as	as	IN	B-PP	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	JJ	B-NP	O
LENIS	LENIS	NN	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
before	before	IN	B-SBAR	O
d/c	d/c	NN	B-NP	O
lovenox	lovenox	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Dean	Dean	NNP	I-NP	O
Cooke	Cooke	NNP	I-NP	O
AND	AND	NNP	I-NP	O
pcp	pcp	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GETTO	GETTO	NNP	B-NP	O
,	,	,	O	O
LEO	LEO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SB2	SB2	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/3/01	3/3/01	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

